Accepted Manuscript Characterizing the biological and biochemical profile of six different scorpion venoms from the Buthidae and Scorpionidae family Sebastian Estrada-Gómez, Lyz Gomez-Rave, Leidy Vargas-Muñoz, Arie van der Meijden PII:
S0041-0101(17)30054-5
DOI:
10.1016/j.toxicon.2017.02.007
Reference:
TOXCON 5563
To appear in:
Toxicon
Received Date: 2 December 2016 Revised Date:
8 February 2017
Accepted Date: 11 February 2017
Please cite this article as: Estrada-Gómez, S., Gomez-Rave, L., Vargas-Muñoz, L., van der Meijden, A., Characterizing the biological and biochemical profile of six different scorpion venoms from the Buthidae and Scorpionidae family, Toxicon (2017), doi: 10.1016/j.toxicon.2017.02.007. This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
ACCEPTED MANUSCRIPT
AC C
EP
TE D
M AN U
SC
RI PT
MCF-7 cells
ACCEPTED MANUSCRIPT
1 2 3
Characterizing the biological and biochemical profile of six different scorpion venoms from the Buthidae and Scorpionidae family.
4 5
RI PT
Characterization of six different scorpion venoms.
6 7 8
Sebastian Estrada-Gómez1,2 *, Lyz Gomez-Rave 1,3, Leidy Vargas-Muñoz 4, Arie van der Meijden 5.
10
SC
9
1. Programa de Ofidismo/Escorpionismo - Serpentario, Universidad de Antioquia UdeA,
12
Carrera 53 No 61-30, Medellín, Zip code 050010, Antioquia, Colombia.
M AN U
11
2. Facultad de Ciencias Farmacéuticas y Alimentarias, Universidad de Antioquia UdeA, calle
13
70 No 52-21, Medellín, Zip code 050010, Antioquia, Colombia. E-Mail:
14
[email protected]
15
3. Maestría Bioquímica Clínica, Facultad de Ciencias de la Salud, Colegio Mayor de Antioquia,
16
Medellín, Zip code 050040, Antioquia, Colombia. E-mail:
[email protected] 4. Facultad de Medicina, Universidad Cooperativa de Colombia, Calle 50 A No 41-20
TE D
17 18
Medellín, Zip code 050012, Antioquia, Colombia. E-Mail:
19
[email protected]
20
5. CIBIO, Centro de Investigação em Biodiversidade e Recursos Genéticos, Universidade do Porto, Campus Agrário de Vairão, P-4485-661 Vila do Conde, Portugal. E-mail:
22
[email protected]
EP
21
24 25
AC C
23
* Corresponding autor: Sebastian Estrada-Gómez,
[email protected]
26
Abstract
27
The objective of this study was to characterize a selection of six different scorpion venoms using
28
biological and biochemical methods, including a preliminary MS/MS and a post-translational
29
modifications analysis. Despite the diversity of scorpion species of medical importance in Africa 1
ACCEPTED MANUSCRIPT
and Colombia, the venoms of these arachnids have been poorly studied in these two regions. We
31
report the biochemical, electrophoretic, chromatographic profile, internal peptide sequences with
32
a post-translational modification report, and a preliminary antitumor activity of five different
33
scorpions of the Buthidae family, Androctonus amoreuxi, Babycurus jacksoni, Grosphus grandidieri,
34
Hottentotta gentili and Tityus fuhrmanni, and one of the Scorpionidae family Pandinus imperator.
35
No L-amino oxidase activity was detected in the evaluated venoms. Proteolytic activity using
36
azocasein was detected only in G. grandidieri and P. imperator, indicating the possible presence of
37
metalloproteinases in these two venoms. Proteolytic activity using NOBA was detected in all
38
venoms indicating the presence of serine-proteinases. Phospholipase A2 activity was detected in
39
the venoms of P. imperator, G. grandidieri, H. gentili and A. amoreuxi, with P. imperator venom
40
being the most active. All venoms analyzed contained defensin-like proteins, alpha toxins,
41
metalloproteinases, neuropeptides, DBP affecting ion channels, DBP with antimicrobial activity,
42
among others. Venoms from P. imperator, G. grandidieri and T. fuhrmanni showed a dose-
43
dependent cytotoxic activity over MCF-7 cells. Only two isolated RP-HPLC fractions from P.
44
imperator and T. fuhrmanni showed cytotoxic activity over MCF-7. No cytotoxic activity was found
45
in the venoms from A. amoreuxi, B. jacksoni, and H. gentili.
SC
M AN U
TE D
EP
46
RI PT
30
Keywords: Grosphus, Babycurus, Hottentotta, Tityus, metalloproteinases, phospholipases,
48
antitumor, MCF-7, post-translational modifications.
49 50
AC C
47
1. Introduction.
51
2
ACCEPTED MANUSCRIPT
Understanding the composition and mode of action of scorpion venom is important for both the
53
treatment of victims of scorpionism, as well as the potential applications of the compounds of
54
scorpion venom for antimicrobial and anti-cancer applications. For scorpion species in several
55
geographic areas, such knowledge is sorely lacking.
56
RI PT
52
Although there is not any official report from minister of health, scorpions accidents in Colombia
58
have been rising every year, with deaths reported in localities where the most lethal scorpions
59
(family Buthidae) can be found, such as the Magdalena River in the states of Antioquia (one this
60
year), Cundinamarca, Huila, Tolima and Valle del Cauca (1). One of the best epidemiology reports
61
comes from the Toxicology Information Center from the Universidad Nacional de Colombia
62
(CIGITOX). This report is based on telephonic medical inquiries where they receive around 90
63
accidents consults every year (1). Although Tityus fuhrmanni is not the most lethal Buthidae
64
scorpion distributed in Colombia, this scorpion can be found in densely populated areas, like the
65
Aburra Valley (Medellín), inhabited by more than 3 million people. Hospitals from this city have
66
attended T. fuhrmanni accidents on newborns, children and adults. Unfortunately the venom of
67
this important scorpion was hitherto not characterized.
M AN U
TE D
EP
AC C
68
SC
57
69
According to Chippaux and Goiffon, the genera Androctonus and Hottentotta are among the most
70
deadly or potentially deadly scorpions in Africa (2). There are no any epidemiological reports
71
about G. grandidieri in Madagascar. Pandinus imperator is mainly distributed in the mainland of
72
western Africa. Although this scorpion is one of the largest species in the world, the venom is not
73
very dangerous for humans (2). The characterization of all these venoms is still incipient, except
74
the venom from A. amoreuxi and P. imperator, were many different toxins have been reported 3
ACCEPTED MANUSCRIPT
75
and characterized. Hottentotta gentili and G. grandidieri venoms have to date not been studied at
76
all.
RI PT
77 Scorpion venoms have evolved over 400 million years into complex libraries of toxins affecting
79
different systems, with a remarkable affinity for the nervous system. The variety of protein
80
(peptides, proteins and enzymes) and non-protein compounds (salts, neurotransmitters, etc.)
81
make these venoms a promising target to identify molecules with antibacterial, antifungal,
82
antiviral, antimalarial and anticancer activities (3-5), and a novel potential source for the design of
83
new drugs (6, 7). The most active molecules displaying such activities are peptides showing both
84
non-disulphide bridge (NDBP) or disulphide bridge (DBP) structures, presenting linear motifs or
85
inhibitory cysteine knots respectively. Disulfide-rich peptides are the major molecules in this
86
venom, containing around 30 to 70 amino acids residues and three or four disulfide bridges (4, 8-
87
15). These toxins’ major targets are the ion channels in the nervous system, like sodium (Nav),
88
potassium (Kv), chlorine (Cl) or calcium (Cav) channels, blocking or gating the channel mechanism
89
and thereby exhibiting a neurotoxic activity. The non-disulfide rich compounds were discovered
90
recently. The main characteristics of these molecules are the lack of disulfide bridges, the diverse
91
sequences, the hemolytic and antibacterial activity, and the relatively low molecular mass (1-4
92
kDa). Most of these peptides possess an amphipathic α-helical structure like those reported for
93
different cationic antimicrobial molecules (4, 8-15). Post-translational modifications (PTM) play a
94
key role in functional proteins like the mentioned above, giving higher complexity and peptide
95
diversity of venoms. Despite the importance of this feature, there is not enough literature of these
96
relevant modifications described for scorpion venoms.
AC C
EP
TE D
M AN U
SC
78
97
4
ACCEPTED MANUSCRIPT
Anticancer peptides (ACPs) can be classified into two groups; those affecting microbial and cancer
99
cells or those affecting microbial and cancer cells plus healthy mammalian cells (16). Although the
100
mechanism of action of ACPs is still controversial, their effects occur either by membranolytic or
101
non-membranolytic mechanisms (16, 17). Membranolytic mechanism are related to linear NDBP
102
peptides showing an amphipathic moiety, most of them containing cationic and hydrophobic
103
residues capable of interacting with microbial- or cancer cell membranes. This interaction is due to
104
the increased anionicity of the cytoplasmic membrane of these cells, disrupting membranes and
105
altering membrane permeability (5, 16). Non-membranolytic mechanisms are related to the
106
interaction of ACPs with membrane proteins, altering their function, which is similar to the
107
mechanism affecting ionic channels. Until today, only one snake Zn-metalloproteinase from
108
Porthidium nasutum was reported to induce specific apoptosis activity in JurKat (T-cell acute
109
lymphocytic leukemia) and K562 (Chronic myeloid leukemia) cells (Bonilla 2016).
M AN U
SC
RI PT
98
TE D
110
Different venoms and toxins have been reported affecting MCF-7 adenocarcinoma mammary cells,
112
such as maurocalcine from Scorpio maurus (18) and BmK-CBP from Mesobuthus martensii. The
113
latter is a serine protease that recognizes and binds to the membrane of these cells (19). Two
114
linear peptides from Tityus serrulatus have been reported to affect these cancer cell lines (20).
AC C
115
EP
111
116
Here we report the biological and biochemical activity, as well as the electrophoretic and
117
chromatographic profile, MS sequence together with a PTM report, and a potential antitumor
118
activity of the complete venoms and fractions of Androctonus amoreuxi (Buthidae), Babycurus
119
jacksoni (Buthidae), Hottentotta gentili (Buthidae), Grosphus grandidieri (Buthidae), Tityus
120
fuhrmanni (Buthidae), and Pandinus imperator (Scorpionidae). No previous report regarding 5
ACCEPTED MANUSCRIPT
121
venom characterization or their biological activities have been published for the species Babycurus
122
jacksoni, Hottentotta gentili, Grosphus grandidieri and Tityus fuhrmanni.
124
RI PT
123 2. Materials and Methods.
125 2.1. Venom extraction.
SC
126
Androctonus amoreuxi from Egypt, Babycurus jacksoni from Tanzania, Grosphus grandidieri from
128
Madagascar, Hottentotta gentili from Morocco and Pandinus imperator from Togo, Africa and
129
Tityus fuhrmanni from Colombia, specifically from the Antioquia province (North-west Andean
130
region) were kept in captivity with water ad libitum and food offered every 2-3 weeks in a
131
polyphagic diet of arthropods. Venom extraction as carried out using electro-stimulation. Metal
132
electrodes, impregnated with a saline solution, were carefully positioned on the metasoma and a
133
block signal with an amplitude of 18V at 40-60Hz was applied twice with an interval of 5 sec using
134
a custom-made electro-stimulator (model 01). Collected venom was transferred to dry low-protein
135
binding vials, lyophilized and stored at -20°C until use. These procedures were in accordance with
136
the ethical principles in animal research adopted by the World Health Organization for the
137
characterization of venoms (21, 22). These procedure were analyzed by the Comité Institucional
138
para el Cuidado y Uso de animales - CICUA. After each extraction, all animals were kept alive in
139
captivity.
AC C
EP
TE D
M AN U
127
140 141
2.2. Electrophoretic profile.
6
ACCEPTED MANUSCRIPT
All electrophoretic profiles of all crude venoms were analyzed using 12% sodium dodecyl sulfate
143
polyacrylamide gels (SDS-PAGE) according to Laemmli (23), and stained with Coomassie blue R-
144
250. Venoms were loaded at a concentration of 1.5 mg/ml and a final volume of 20 µl. Molecular
145
weights were estimated using standard low rank markers (Bio-Rad).
146 2.3. Chromatographic profile.
SC
147
RI PT
142
One milligram of whole venom was dissolved in 200 μL of solution A (0.1% TFA in water) and
149
centrifuged at 3500 g. The supernatant was then applied to a reverse-phase RESTEK C18 column
150
(250×4.6 mm), and separated on a Shimadzu Prominence HPLC. Proteins were eluted by a gradient
151
towards solution B (0.1% TFA in acetonitrile) as follows: 5% B for 5 min, 5–15% B over 10 min, 15–
152
45% B over 60 min, and 45–70% B over 12 min at a flow rate of 1.0 mL/min (24). The
153
chromatographic run was monitored at 215 nm and fractions were collected, lyophilized and
154
stored until used.
155 2.4. PLA2 activity.
EP
156
TE D
M AN U
148
PLA2 activity of all venoms was measured using the assay described by Cho and Kézdy (25) and
158
Holzer and Mackessy (26), modified for 96-well plates. The standard assay mixture contained 200
159
μL of buffer (10 mMTris–HCl, 10 mM CaCl2, 100 mMNaCl, pH 8.0), 20 μL of substrate NOBA, 20 μL
160
of water and 20 μL of the venom at a concentration of 5 µg/μL, or the RP-HPLC collected fractions
161
(positive in the indirect hemolytic assay), in a final volume of 260 μL. The mixture was incubated
162
for 60 min at 37 °C, and the absorbance was recorded at 405 nm. Each test was performed in
163
triplicate.
AC C
157
7
ACCEPTED MANUSCRIPT
164 165
2.5. Proteolytic activity. Azocasein (Sigma–Aldrich, St. Louis, MO) was used as substrate to measure the proteolytic activity
167
of all venoms, and to determine the presence of metalloproteases, according to Wang et al, (27)
168
with some modifications. Briefly, 5 and 2.5 μg of the venom were dissolved in 20 μl of 25 mM Tris
169
(0.15 M NaCl, 5 mM CaCl2), pH 7.4. These solutions were incubated with a solution of azocasein at
170
a concentration of 10 mg/ml, previously diluted in the same buffer. After 90 min of incubation at
171
37 °C, the reaction was stopped by adding 200 μl of trichloroacetic acid. Samples were then
172
centrifuged at 360 g for 5 min. Supernatant (100 μl) was mixed with an equal volume of 0.5 M
173
NaOH, and the absorbance was measured at 450 nm. Results are shown as units of proteolytic
174
activity, which correspond to the amount of enzyme that induces a change in absorbance of 0.2.
175
Each test was performed in triplicate.
TE D
176
M AN U
SC
RI PT
166
A second proteolytic activity assay was performed on all venoms to determine the presence of
178
serine protease enzymes following the method described by Patiño et al (28). The enzymatic
179
activity was measured using the synthetic substrate N-alpha-benzoyl-DL-arginine-p-nitroanilide
180
(BapNA). The standard assay mixture contained 50 μL of buffer (10 mM Tris–HCl, 10 mM CaCl2,
181
100 mM NaCl, pH 8.0), 200 μL of substrate, 10 μL of water or enzyme in a final volume of 260 μL.
182
After the addition of 2.5 µg/µl of each venom, the mixture was incubated for up to 40 min at 37
183
°C, with the absorbance at 405 nm being recorded at 10 min intervals. Each test was performed in
184
triplicate.
AC C
EP
177
185
8
ACCEPTED MANUSCRIPT
186
2.6. LAAO activity. The assay was performed in triplicate, using 96-well microplates. Ten microliters of the enzyme
188
solution (1 µg/µL) were added per well with 90 µL of the substrate solution to start the reaction.
189
The standard reaction mixture consisted of 250 µM of L-leucine, 2 mM o-phenylenediamine (OPD),
190
0.8 U/mL horseradish peroxidase and BSLAAO in a total volume of 100 µL of 50 mMTris–HCl buffer
191
(pH 8) per well. After incubation at 37° C for 60 min the reaction was stopped by adding 50 µL of
192
2M H2SO4. As negative control, distilled water was used. The absorbance of the reaction mixture
193
was recorded at 492 nm using a microplate reader (Awareness Technology, FL, USA) (29). The
194
enzyme activity was expressed as the increase of absorbance after the incubation time. All assays
195
were performed in triplicate.
196
2.7. Peptide mass determination by High-Resolution LC-MS.
TE D
197
M AN U
SC
RI PT
187
We selected from the RP-HPLC chromatograms peaks with the best intensity and resolution.
199
Unfortunately, we did not have enough H. gentili sample for the preliminary MS/MS analysis. The
200
only exception were the venoms from P. imperator and T. fuhrmanni. In these two venoms, we
201
analyzed the fractions enhancing cytotoxic activity over MCF-7 cells. In all cases, the selected dried
202
fractions were digested and submitted into the MS/MS equipment.
204
AC C
203
EP
198
2.7.1. Sample Digestions.
205
Sequence grade Lys-C/Trypsin (Promega) was used to enzymatically digest the venom samples.
206
The samples were reduced and alkylated. All digestions were carried out in the Barocycler
207
NEP2320 (PBI) at 50°C under 20 kpsi for 2 hours. Digested samples were cleaned over C18 spin
9
ACCEPTED MANUSCRIPT
208
columns (Nest Group) and dried. Resulting pellets were resuspended in 97% purified H2O/3%
209
ACN/0.1% formic acid (FA). A volume of 5 µL was used for nano LC-MS/MS analysis.
211
RI PT
210 2.7.2. LC-MS/MS.
Fractions were run on a nano Eksigent 425 HPLC system coupled to the Triple TOF 5600 plus
213
(Sciex, Framingham, MA). The method used for analysis was 120 minutes at 300 nL/minute over
214
the cHiPLC nanoflex system. The trap column was a Nano cHiPLC 200 µm x0.5 mm ChromXP C18-
215
CL 3 µm x 120 Å followed by the analytical column, the Nano cHiPLC 75 µm x 15 cm ChromXP C18-
216
CL 5 µm x 120 Å. The sample was injected into the Triple TOF 5600 and through the Nanospray III
217
source equipped with an emission tip (New Objective). Peptides from the digestion were eluted
218
from the columns using a mobile phase A of purified H2O/0.1% formic acid (FA) and a mobile
219
phase B of ACN/0.1 % FA. With a flow rate of 0.3 µl/min, the method started at 95% A for 1
220
minute followed by a gradient of 5% B to 35% B in 90 minutes and from 35% B to 80% B in 2
221
minutes. Eighty percent of B was held for 5 minutes before being brought to 5% B and held for
222
20 minutes. PTM are reported for each containing peptide.
M AN U
TE D
EP
224
2.7.3. Data analysis.
AC C
223
SC
212
225
The data acquisition was performed monitoring 50 precursor ions at 250 ms/scan. Mascot
226
Daemon v.2.4.0 (Matrix Science) was used for database searches against the different databases.
227
Some fragments were downloaded from UniProt or NCBI website . Samples were run in the
228
Bindley Bioscience Center at Purdue University.
229 10
ACCEPTED MANUSCRIPT
230
2.8. Antibiotic activity. All venoms were analyzed. Antibiotic susceptibility tests were performed as proposed by Bauer et
232
al. (30), and the Clinical and Laboratory Standards Institute (CLSI) guidelines, with some
233
modifications. Escherichia coli (ATCC 25922) and Staphylococcus aureus (ATCC 25923) were grown
234
on Mueller-Hinton agar (MH) and then suspended in 5ml of MH sterile broth. Turbidity was
235
measured at 600nm and adjusted to 0.5 absorbance which corresponds to 1.5 x 10-4 colony
236
forming units (CFU). Ten μl of each venom dose containing 500 and 250 µg, and RP-HPLC collected
237
fractions were added and incubated at 37°C during 24 hours. Physiological saline solution was
238
used as negative control and chloramphenicol as a reference control. Each test was performed in
239
duplicate.
240 2.9. Cytotoxicity over tumor cells.
TE D
241
M AN U
SC
RI PT
231
All venoms were evaluated against MCF-7 cells (adenocarcinoma mammary cells). Only the RP-
243
HPLC fractions from those venoms enhancing cytotoxic activity were evaluated against the same
244
cell line. In this case we selected peaks with the best intensity and resolution. Each test was
245
performed in triplicate.
247
AC C
246
EP
242
2.9.1. Cell cultures.
248
MCF-7 cells were cultivated using DMEM supplemented with 5% of SBF, 100 µg/ml of penicillin
249
and 100 µg/ml of streptomycin. All were incubated at 37ºC using a 5% atmosphere of CO2.
250 251
2.9.2. Cell viability. 11
ACCEPTED MANUSCRIPT
Twenty-four-well plates were used to seed 5 × 104 MCF-7 cells and kept under normal conditions
253
of culture incubated for 24 h to guaranty the adhesion. After this initial incubation period, the cell
254
cultures were treated using complete venoms and their respective fractions in triplicate.
255
Treatment of each compound was carried out for 24 h, and after this period of exposure, cells
256
were detached using a solution of tripsine-EDTA (0.1%). A solution of trypane-blue (0.4%) was
257
used to quantify the cell viability using a hemocytometer. The percentage of live cells was
258
determined dividing the number of live cells by the total number of cells. Each test was performed
259
in triplicate.
260 261
2.9.3. Cytotoxic assay.
M AN U
SC
RI PT
252
Dose-dependent cytotoxicity was examined using the MTT assay. Ninety six-well plates were used
263
to seed 2 × 104 MCF-7 cells, and incubated for 24 h to guaranty the adhesion. After this initial
264
incubation period, cell cultures were treated using complete venoms and their respective fractions
265
in triplicate. Treatment of each compound was carried out for 24 h, and after this period of
266
exposure, 10μl de MTT (5 mg/ml) were added into each well with a final concentration of 0.5
267
mg/ml and incubated for 4 h under darkness conditions. Finally, to dissolve all formazan crystals
268
formed, 100 µl of isopropanol/HCl 0.04M was added and the absorbance was measured at 570 nm
269
using a 96-well plat lector. Viability was expressed as a percentage compared to the negative
270
control. All assays with complete venoms and selected RP-HPLC fractions were performed in
271
triplicate. Concentration of the RP-HPLC fractions were determined using a BSA kit.
AC C
EP
TE D
262
272 273 274
2.10. Statistical analysis. 12
ACCEPTED MANUSCRIPT
275
Results were expressed as mean ± standard error media (S.E.M.) and statistical comparisons were
276
done using an ANOVA with a Bonferroni post-test assuming a significance of p<0.05. All data
277
analysis was done using GraphPad PRISM 5 (GraphPad Software, Inc; La Jolla, California, USA).
279
RI PT
278 3. Results.
SC
280 Electrophoretic profile.
282
Each venom shows a specific profile, most of the compounds present on the venoms have
283
molecular masses above 21 kDa and below 97 kDa (red bracket on Fig 1). A few compounds over
284
97 kDa are observed in all venoms (see Fig 1). Venoms from G. grandidieri (Gg), Pandinus
285
imperator (Pi) and Hottentotta gentili shows a similar electrophoretic profile with common bands
286
between 21 kDa and 31 kDa, close to 31 kDa and close to 45 kDa.
AC C
EP
TE D
M AN U
281
287 288
Fig 1: Scorpion venoms electrophoretic profiles. 13
ACCEPTED MANUSCRIPT
Crude venom (reduced) SDS-PAGE profile of all scorpion species in a 12% gel followed by
290
Coomassie blue staining. Venoms were loaded at a concentration of 1.5 mg/ml and a final volume
291
of 20 µl. MW: Molecular Weight, Gg: Grosphus grandidieri, Aa: Androctonus amoreuxi, Pi:
292
Pandinus imperator, Bj: Babycurus jacksoni, Tf: Tityus fuhermanni, Hg: Hottentotta gentili.
RI PT
289
293 Chromatographic profile.
295
The chromatographic profile showed clear differences between venoms from each species. We
296
obtained well-defined fractions that allowed a posterior collection for the respective MS/MS
297
analysis identification and evaluation of cytotoxic activity over MCF-7 cells (see Fig 2). P. imperator
298
and T. fuhermanni venoms showed a homogenous distribution of hydrophobic and hydrophilic
299
compounds eluting from 0% to 70% of ACN. T. fuhermanni showed a higher concentration of
300
compounds eluting between 30 % and 35 %. In the other venoms, most of the compounds elute
301
between 20% and 40% of ACN indicating a moderate hydrophilic nature of each venom content. 3.
302
After minute 70, we did not found any more fraction eluting on G. grandidieri.
M AN U
TE D
EP AC C
303
SC
294
14
AC C
304
EP
TE D
M AN U
SC
RI PT
ACCEPTED MANUSCRIPT
305
Fig 2: Scorpion venoms chromatographic profiles.
306
RP-HPLC chromatographic profiles of the crude venom of all scorpions using a C18 column (250
307
mm - 4.6 mm). Elution gradient used: 0-70% of acetonitrile (99% in TFA 0.1%). The run was
308
monitored at 215 nm. Roman numbers in chromatograms corresponds to the fractions evaluated
309
against MCF-7 cells. Arrows indicate fraction subjected to MS/MS analysis.
15
ACCEPTED MANUSCRIPT
310 Enzymatic activity.
312
No LAAO activity was detected in the evaluated venoms. Only G. grandidieri and P. imperator
313
venoms were evaluated due to the yellow color of the venom after the lyophilization process and
314
the molecular masses present in the electrophoretic profile matching other LAAO enzymes.
315
Proteolytic activity using azocasein was detected in G. grandidieri and P. imperator using 5 mg of
316
venom with a p<0.05 when compared with the blank. Using 2.5 mg, activity was only detected in
317
G. grandidieri (p<0.05). Proteolytic activity using the substrate N-alpha-benzoyl-DL-arginine-p-
318
nitroanilide (BapNA) was detected in all venoms. G. grandidieri and H. gentili are the most active
319
venoms, with a p<0.0001 when compared with the blank. Phospholipase A2 activity using 4-nitro-
320
3-octanoyloxy-benzoic acid (NOBA) substrate, was detected in the venoms of P. imperator, G.
321
grandidieri, H. gentili and A. amoreuxi. P. imperator is the most active venom with a p<0.0001
322
when compared with the blank. Fig 3 shows the result of the assays.
AC C
EP
TE D
M AN U
SC
RI PT
311
16
TE D
M AN U
SC
RI PT
ACCEPTED MANUSCRIPT
323
Fig 3: Scorpion venoms enzymatic activity.
325
Enzymatic activity of each venom; Pi: Pandinus imperator, Gg: Grosphus grandidieri, Tf: Tityus
326
fuhrmanni, Aa: Androctonus amoreuxi, Hg: Hottentotta gentili, Bj: Babycurus jacksoni, Control:
327
negative control or blank. A: Proteolytic activity using azocasein as substrate (absorbance
328
monitored at 450 nm). B: Proteolytic activity using BapNA as substrate (absorbance monitored at
329
405 nm). C: Phospholiase activity using NOBA as substrate (absorbance monitored at 405 nm). All
330
significant differences are relative to the negative control or blank. **** p<0,0001 / *** p<0,001 /
331
** p<0,01 / * p<0,05.
AC C
EP
324
332 17
ACCEPTED MANUSCRIPT
MS/MS and PTM analysis.
334
After the preliminary MS/MS analysis, fragments showed sequence similarity with proteins from
335
different scorpion species, some of these proteins were reported as neurotoxic, antimicrobial or to
336
display metalloproteinase activity, among others. Table 1 summarizes all preliminary sequences
337
found in the selected fractions. It is important to consider that there are no previous reports of
338
proteomic characterization of T. fuhrmanni, G. grandidieri and B. jacksoni venom, while P.
339
imperator and A. amoreuxi has been widely studied and characterized. In all venoms, except B.
340
jacksoni,
341
/KGMANSGGICNSRWKF/KESIGCANNYTDKC) matching the 25 kDa hypothetical secreted protein
342
from Hottentotta judaicus. In the first fragment the 6th residue can vary to be I (isoleucine), A
343
(alanine), N (asparagine) or V (valine). In all venoms, we found a total of 17 fragments with PTM
344
and the most common PTM were (K) acetylations and (M) oxidations.
found
a
total
of
3
different
fragments
(KISSV[IANVC]NKDKI
M AN U
we
SC
RI PT
333
TE D
345
Given names in P. imperator are just for documentation purposes in this paper since the
347
corresponding proteins already exist and are reported. The fraction from P. imperator with
348
cytotoxic activity over MCF-7 cells showed fragments with 100% sequence similarity with three
349
different toxins affecting potassium channels (see table 1A). PiP1 fragments matched a potassium
350
channel toxin KTx 7.1 corresponding to the signal peptide (PiP1b and PiP1c) and the mature toxin
351
(Pip1a) (see Fig 4). PiP2 fragments, shows amino acid sequence similarity with the potassium
352
channel toxin KTx 6.1, a four disulfide bridge toxin. PiP2a is part of PiP2b leaving one complete
353
fragment KCRGTSDCGRPCQQQTGCPNSKC corresponding to 65.7% of the complete related toxin. In
354
addition to these fragments, other sequences were detected matching with two different peptides
AC C
EP
346
18
ACCEPTED MANUSCRIPT
355
affecting potassium channels reported in the scorpion Heterometrus laoticus, and one putative
356
metalloprotease fragment from Hottentotta judaicus.
RI PT
357 The fraction from G. grandidieri showed amino acid sequence similarity with proteins like a
359
hypothetical secreted protein from Hottentotta judaicus (like the same found on P. imperator), a
360
NADH dehydrogenase subunit from Tityus discrepans and a two fragments showed sequence
361
similarity with a defensine-like peptide (see table 1B).
M AN U
362
SC
358
In the active fraction against MCF-7 cells of T. fuhrmanni, we found fragments matching four
364
different metalloprotease-like proteins from different scorpion species, some of which were
365
reported as zinc dependents (see table 1C). In the same fraction, one fragment showed 100%
366
amino acid sequence similarity with different segments of an antimicrobial peptide from the
367
scorpion Urodacus yaschenkoi. The same hypothetical secreted protein from Hottentotta judaicus
368
detected on P. imperator and G. grandidieri were found in this venom with an additional fragment
369
(K-ESIGCANNYTDK-C). The same fraction of the NADH dehydrogenase fragment detected on G.
370
grandidieri was found in this venom. Additionally, one fragment of an antimicrobial peptide was
371
found.
EP
AC C
372
TE D
363
373
The fraction from A. amoreuxi showed sequence similarity with toxins from other Buthidae genera
374
like Buthus, Mesobuthus, Leiurus, and Isometrus, some of them distributed in North Africa (see
375
table 1D). Additionally, A. amoreuxi showed sequence similarity specifically with other
376
Androctonus species like A. australis and A. crassicauda (see table 1D). Sequences found in A.
19
ACCEPTED MANUSCRIPT
amoreuxi correspond to alpha and beta toxins, insect toxins and toxins affecting sodium channels.
378
AaP1 fragments are similar with the mature peptide of the beta-insect excitatory toxin from
379
Androctonus australis and the beta-toxin Isom1 from Isometrus vittatus. AsP1d fragment is part of
380
the protein N-terminal (see Fig 5). All sequences that we reported matching beta toxins are
381
identical to the respective toxin. The AsP3a fragment is part of the C-terminal portion of the
382
matched alpha-toxin from Buthus occitanus tunetanus. Two fragments showed sequence similarity
383
with toxins affecting sodium and potassium channels, and one more has sequence similarity with a
384
neuropeptide from Mesobuthus eupeus. Interestingly, the same hypothetical secreted protein
385
found in P. imperator, G. grandidieri and T. fuhrmanni, was found in A. amoreuxi but only the
386
Isoleucine (I) variant.
M AN U
SC
RI PT
377
387
The analyzed fraction from B. jacksoni gave different sequences, all reported for first time in this
389
species. Only two of the five fractions showed a score above 100. Sequences showed sequence
390
similarity with alpha toxins, neurotoxins, and other proteins from different scorpions. Although
391
scores are very low in some cases, is important to consider that is the first report of this venom.
392
We also found possible isomers of the protein kinase reported in Mesobuthus gibbosus with amino
393
acids varying on position 7th of the internal peptide found (RMMDPK[MNAIY]SKR). The alpha-like
394
toxin fragment corresponds to the C-terminal portion of the complete protein.
EP
AC C
395
TE D
388
396
Table 1: Venoms preliminary MS/MS analysis and their respective similar peptide or protein.
397
Summary of the identified fragments in A: Pandinus imperator. B: Grosphus grandidieri. C: Tityus
398
fuhrmanni. D: Androctonus amoreuxi. E: Babycurus jacksoni. All MS/MS derived sequences
399
correspond to internal peptides. All database numbers are from UniProtKB, only PiP5a is from 20
ACCEPTED MANUSCRIPT
GenBank. Z: charge. Amino acid within brackets [ ] on the hypothetical secreted protein and the B.
401
jacksoni protein kinase like sequence indicates that those amino acids con vary on that position.
402
Superscript £ indicates molecular weight calculated with alanine residue and without any PTM.
403
Superscript ¥ indicates molecular weight calculated with methionine residue and 2 methionine
404
oxidations. Asterisk (*) indicates fragments with (K) acetylations and pilcrow (¶) indicates
405
fragments with (M) oxidations.
RI PT
400
PiP2a
PiP2b PiP3a PiP4a
PiP5a PiP6a
K-ETGYPNAK-C K-TISCTNPK-Q KDDDDKTISCTNPK -Q RGTSDCGRPCQQQ TGCPNSK-C KCRGTSDCGRPCQ QQTGCPNSK-C
362 362
K-ETGYPNAK-C
240
*KISSV[IANVC]NKD K-I ¶ KGMANSGGICNSR WK-F
P55927
362
282
Q10726
282
KKTGCPNAKC
Expected peptide m/z
Z
Calculated peptide mass
440.209 454.227
+2 +2
878.413 906.448
499.207
+3
1494.651
525.478
+4
2097.88
Pandinus imperator
601.262
+4
2401.024
Pandinus imperator
878.413
Pandinus imperator
M AN U
PiP1c
Matching peptide acc. number
Score
Matched peptide family
Potassium channel toxin.
TE D
PiP1a PiP1b
MS/MS peptide sequence
Potassium channel toxin.
Matched organism
Pandinus imperator
P55928
Potassium channel toxin.
440.209
+2
F1CJ08
Hypothetical secreted prot.
£ 502.296
+2 1002.571
20
GB HQ288187
Metalloproteinas e
770.849
+2
1539.692
Hottentotta judaicus
18
C0HJN0
α-toxina KTx6
431.71
+2
861.437
Hottentotta laoticus
EP
Fragment given name
A: Pandinus imperator.
26
AC C
407
SC
406
£ Hottentotta judaicus
408 409
B: Grosphus grandidieri.
21
ACCEPTED MANUSCRIPT
Fragment given name
MS/MS peptide sequence
Score
Matching peptide acc. number
Matched peptide family
Expected peptide m/z
GgP1a
* KISSV[IANVC]NKD K-I
46
F1CJ08
Hypothetical secreted prot.
£ 502.296
+2 1002.571
GgP2a
R-GILTVIPR-I
28
C9X4I7
NADH dehydrogenase
434.766
+2
867.554
GgP3a
* R-KTPTPEK-R
17
Defensine-like
421.759
+2
841.454
Defensine-like
435.756
+2
869.460
GgP3b
17
* K-TPTPEKR-E
TfP1a TfP1b
MS/MS peptide sequence
Score
* KISSV[IANVC]NKDKI K-ESIGCANNYTDKC
+2
1260.711
Tityus pachyurus.
631.364
+2
1260.711
Tityus sp.
412.751
+2
823.491
574.958
+2
1721.816
687.333
+2
1372.619
690.369
+2
1378.764
15
531.271
+3
1590.844
17 17
421.758 435.755
+2 +2
841.454 869.460
593.613
+3
1777816
979,4
+2
979.406
R-TIPPGAIR-A ¶ KYMEVYIFNLMNAA K-N * KINGMKFSPCCK-R ¶ KMLFNTLDLRIK-V RVQEVYLANLMNAV K-M * R- KTPTPEK-R * K-TPTPEKR-E KFKGACLSSSNCASIC R-T
18
V9Z548
Venom metalloproteinase Antarease-like Znmetalloprotease
V9Z553
F1CIY1
Putative M12B metalloprotease.
EP
18 15
AC C
* K-EGYCHGTK-C
Matched organism
631.364
TfP4a
TfP7a
Calculated peptide mass
1399.593
35
TfP6c
Z
+2
¶ K-SADIIMLLITR-T
TfP6a TfP6b
Expected peptide m/z
Tityus discrepans Aegilops tauschii Aegilops tauschii
700.805
44
TfP3a
TfP5c
F1CJ08
Hypothetical secreted protein.
£ Hottentotta judaicus
+2 1002.571
35
TfP5b
Matched peptide family
Matched organism
£ 502.296
¶ K-SADIIMLLITR-K
TfP5a
Matching peptide acc. number
44
TfP2a
TfP4b
M AN U
Fragment given name
C: Tityus fuhrmanni.
TE D
411
SC
410
Calculated peptide mass
RI PT
R7W9E7
Z
15
E4VNZ7
R7W9E7
17 18
L0GCW2
Venom metalloprotease.
Defensin-like protein. Antimicrobial peptide
£ Hottentotta judaicus.
Hottentotta judaicus.
Mesobuthus eupeus.
Aegilops tauschii. U. yaschenkoi 22
ACCEPTED MANUSCRIPT
TfP8a
R-GILTVIPR-I
28
C9X4I7
NADH dehydrogenase
434.766
Matched peptide family
Expected peptide m/z
Z
Calculated peptide mass
530,800 530,800
+2 +2
1059,592 1059,592
499,229
+2
996,451
601,288
+2
1200.562
499,229
+2
996,451
+2
867.554
Tityus discrepans
412
AaP1c AaP1d AaP2a
Score
K- KVLEISDTR-K K-VLEISDTRK-S K- NGYAVDSSGKA R-KSYCDTTIIN K-NGYAVDSSGKV
Matching peptide acc. number
1068 1068
P01497
Beta-insect toxin.
1068 1068 198
O61668
Beta-insect toxin
LKDGYIVDDR-N
113
P01486
AaP4a
K- ALPDNVPIK-D
25
M1JBC0
23
A0A088D9U2
AaP6a
AaP7a
KLTSMSEYACPVIE K-W RNFDEIDNVGFND FGPASRPGSGR-S * KISSV[IANVC]NKD K-I
Fragment given name
BjP1a BjP2a
Mesobuthus martensii Buthus occitanus tunetanus Androctonus crassicauda
597,308
+2
1192,608
Sodium channel alpha-toxin
483,782
+2
965,554
Potassium channel blocker
807,888
+2
1613,768
Mesobuthus eupeus
E4VP42
Venom neuropeptide
823,377
+3
2467,115
Mesobuthus eupeus
F1CJ08
Hypothetical secreted protein.
£ 502.296
+2
1002.571
£
Hottentotta judaicus.
E: Babycurus jacksoni.
AC C
415
44
Androctonus australis.
EP
414
20
Matched organism
Alpha-toxin
TE D
AaP3a
AaP5a
RI PT
AaP1a AaP1b
MS/MS peptide sequence
SC
Fragment given name
D: Androctonus amoreuxi.
M AN U
413
Score
Matching peptide acc. number
Matched peptide family
Expected peptide m/z
Z
Calculated peptide mass
207
P58779
Alpha-like toxin
504,736
+2
1007,492
K-EGYPVDWGNCK118 Y
E7CLN7
Alpha-neurotoxin
656,272
+2
1310,560
433,213
+2
864,448
MS/MS peptide sequence
* KDGYPVDSK-G
BjP3a
R-ICSARSGK-F
32
H6UDU1
Defensin-like protein
BjP3a
*¶ RMMDPK[MNAIY]S K-R
19
Q7Z1X7
Protein kinase
500.002
¥
+2
998,423
Matched organism
Centruroides sculpturatus Rhopalurus junceus Wolffia australiana
¥ Mesobuthus gibbosus 23
ACCEPTED MANUSCRIPT
416
RI PT
417
418
Fig 4: Alignment of PiP1 fragments of P. imperator with potassium channel toxin alpha-KTx 7.1
420
(P55927).
421
Alignment of PiP1 fragments matching the potassium channel toxin alpha-KTx 7.1 (UniProt code:
422
P55927) toxin from P. imperator.
AC C
424
EP
TE D
423
M AN U
SC
419
425
Fig 5: Alignment of A. amoreuxi MS/MS AaP1 fractions.
426
Alignment of fragments of A. amoreuxi matching with a Beta-insect excitatory toxin (UniProt code:
427
P01497) from Androctonus australis.
428 429
Biological activity.
24
ACCEPTED MANUSCRIPT
No antibiotic activity was detected at the doses evaluated. In our measurements of cytotoxic
431
effects using MCF-7 cells after 24 hours of exposure to each venom, no morphological changes or
432
inhibitory growth activity was observed with A. amoreuxi, B. jacksoni and H. gentili venoms when
433
compared with the control (see Fig 6 A, B, C). Venom of G. grandidieri and T. fuhrmanni induced an
434
aggregation and cells adopted a rounded shape (see Fig 6 D, E). With P. imperator venom, the
435
same rounded shape can be observed in the cells, as well as a decrease in their number and size
436
(see Fig 6 F). The measurement of cytotoxic activity using MTT did not result in any detectable
437
activity. Figure 7 shows viability of cells after using trypane blue. All three venoms from P.
438
imperator, G. grandidieri and T. fuhrmanni were effective to reduce viability of cells, with the
439
venom of P. imperator being the more potent. These three venoms were subjected to a new RP-
440
HPLC process and collected fractions were used to measure cytotoxic effects using MCF-7 cells.
441
AC C
EP
TE D
M AN U
SC
RI PT
430
442
Fig 6: Cytotoxic activity of each venom over MCF-7 adenocarcinoma cells.
443
Micrographs obtained using an optical microscope (40x) of MCF-7 cell cultures after 24 hours of
444
exposure to each venom. A: Control, B: Androctonus amoreuxi, C: Babychurus jacksoni, D: 25
ACCEPTED MANUSCRIPT
445
Hottentotta gentili, E: Grosphus grandidieri, F: Tityus fuhrmanni, G: Pandinus imperator. Arrows
446
indicate cellular morphological changes for each venom.
TE D
M AN U
SC
RI PT
447
EP
448
Fig 7: Dose-response relationship of venoms enhancing cytotoxic activity over MCF-7
450
adenocarcinoma cells.
451
Cytotoxic activity of complete venoms and the respective dose-response relationship from
452
Pandinus imperator: Pi, Grosphus grandidieri: Gg and Tityus fuhrmanni: Tf.
AC C
449
453 454
The RP-HPLC collected fractions from those venoms displaying cytotoxic activity over MCF-7 cells
455
were evaluated against the same cell line using trypane blue. Only fraction III of P. imperator and 26
ACCEPTED MANUSCRIPT
fraction I of T. fuhrmanni (see Fig 8) showed cytotoxic activity after 24 h of treatment of MCF-7
457
cells (See Fig 2). Percentage of cell viability were 77% and 68.79% respectively when compared
458
with the control cell viability (p<0.05). No representative activity was observed using fractions
459
from Grosphus grandidieri. After treatment with each fraction, cells lose cohesion and viability
460
(see Fig 8). Fractions suspected to display cytotoxic activity were subjected to MS/MS preliminary
461
analysis. Fractions concentrations for Pi: 4.06 mg/lt and Tf: 11.36 mg/lt.
M AN U
SC
RI PT
456
462
Fig 8: Cytotoxic activity of Tityus fuhrmanni RP-HPLC fraction number I over MCF-7
464
adenocarcinoma cells.
465
Micrographs obtained using an optical microscope (40x) of MCF-7 cell cultures after 24 hours of
466
exposure to fraction number I collected from RP-HPLC of Tityus fuhrmanni (according Fig 2). A:
467
Control. B: RP-HPLC collected fraction Tityus fuhrmanni.
469
EP
AC C
468
TE D
463
4. Discussion.
470 471
Pharmaceutical research has focused efforts on venoms as a potential source of bio-active
472
compounds. The high diversity of molecules found in venoms is one of the main reasons to 27
ACCEPTED MANUSCRIPT
473
propose these venoms as potential sources for drug candidates. Scorpion venoms in particular are
474
a rich source of molecules with a diverse range of biological activities like antibacterial, antifungal,
475
antiviral, antimalarial and anticancer activities (3-5).
RI PT
476
The electrophoretic and chromatographic profile obtained, showed a specific outline to each
478
species. We report the biochemical analysis of six different venom including in the cases of B.
479
jacksoni, G. grandidieri and T. fuhrmanni the first MS/MS and TPM analysis of the venom. We
480
found significant, dose-dependent cytotoxic activity on MCF-7 mammary carcinoma cell lines in
481
the venoms of P. imperator, G. grandidieri and T. fuhrmanni, indicating the possible anticancer
482
activity of these three venoms. This activity may be associated with the presence of different
483
proteins and peptides found in these venoms, acting synergistically as discussed below.
M AN U
SC
477
TE D
484
Scorpion venoms are widely known for the rich content of toxins affecting sodium channels (31,
486
32). The biochemical profiles of the scorpion venoms evaluated indicate that the venoms of these
487
scorpions contains proteins with enzymatic activity. Only P. imperator, G. grandidieri and T.
488
fuhrmanni venoms may contain proteins displaying metalloproteinase activity. Electrophoretic
489
analysis corroborates these findings, due to the different conserved bands with molecular masses
490
close to 31 and 45 kDa observed in all three venoms. This is a common molecular mass of
491
metalloproteinases (33). In addition, we found the sequences of at least three different internal
492
peptides, in T. fuhrmanni and P. imperator, matching metalloproteinases previously reported in
493
other scorpions like Tityus, Mesobuthus and Hottentotta. For instance, BumaMPs1 was isolated,
494
identified and cloned from the scorpion Mesobuthus martensi; Metalloproteinases VP-1 (GenBank
495
EF442045) and VP-2 (GenBank EF442046) were isolated from Mesobuthus eupus; Antarease-like
AC C
EP
485
28
ACCEPTED MANUSCRIPT
proteins were identified from Tityus pachyurus and one other Tityus species. (34-36) (37, 38). The
497
reported antarease-like proteins are ubiquitous in a broad range of scorpion species, and their
498
catalytic activity is related to the cleavage of vesicle associated membrane proteins (VAMP) of the
499
pancreas, via the cleavage of the soluble N-ethylmaleimide-sensitive factor attachment protein
500
receptors (SNAREs) involved in pancreatic secretion (37). Venoms from Androctonus amoreuxi,
501
Babycurus jacksoni, Grosphus grandidieri, Hottentotta gentili, Pandinus imperator and Tityus
502
fuhrmanni showed the presence of serine-proteinase activity with the higher activity expressed by
503
Hottentotta gentili venom. These kind of enzymes have been previously reported in the scorpion
504
venoms of Tityus serrulatus and Titytus bahiensis (39). Although the physio-pathological effects of
505
serine-proteinases are not clear in scorpion venoms, these proteins have been reported to affect
506
blood coagulation by triggering proteolysis of some coagulation factors as performed by
507
thrombine-like enzymes (40). Pandinus imperator showed the highest level of phospholipase A2
508
(PLA2) activity. This high activity corresponds to the two different Cav dependent phospholipases
509
A2 previously reported; phospholipin (P0DKU2) and imperatoxin-1 (P59888). All other five venoms
510
showed a low to moderate activity, with a difference statistically significant when compared with
511
the blank, indicating the presence of these compounds in all venoms. These kind proteins have
512
been previously reported in other scorpions from Colombia like Opisthacanthus elatus (41). These
513
PLA2 are esterases that cleave glycerophospholipids at the sn-2 ester of phospholipids and has
514
been deeply studied specially in snakes (42).
SC
M AN U
TE D
EP
AC C
515
RI PT
496
516
We found a common sequence in the venoms of A. amoreuxi, G. grandidieri, T. fuhrmanni and P.
517
imperator. The preliminary MS/MS analysis showed 3 different sequences corresponding to a 25
518
kDa secreted protein from H. judaicus with different isoforms varying the amino acids at position
519
138 between I (isoleucine), A (alanine), N (asparagine) and V (valine) (43). We found this similar 29
ACCEPTED MANUSCRIPT
fragments in 5 of the 6 analyzed venoms and showing PTM corresponding to lysine (K)
521
acetylations. The distribution of this protein in the Buthidae family is common in the clade of
522
scorpions from America and Madagascar named “new world” and one clade of the “old world” by
523
Fet et al (44). This protein may correspond to an ancestral toxin shared by the families
524
Scorpionidae and Buthidae. The last phylogenomic study positioned both families in distant clades
525
and different superfamilies indicating that this protein is basal in the parvorder Buthida (45).
526
Further studies must be performed using different individuals from other superfamilies of the
527
same parvororder. The pharmacological and biological activity of this protein still unknown.
SC
RI PT
520
M AN U
528
Venom content from P. imperator showed similarity with toxins affecting potassium channels
530
already reported in this species (46-50). Other, hitherto unreported fragments were found,
531
corresponding to metalloproteinases. This finding suggests an active component related to the
532
proteolytic activity of the venom over the azocasein substrate. After these findings, we can state
533
for first time that the venom of P. imperator contains metalloproteinases. We analyzed for first
534
time the venom from G. grandidieri and the fractions showed sequence similarity with the
535
mentioned hypothetical protein from H. judaicus, and other proteins like NADH dehydrogenase
536
and defensin-like proteins from other scorpions. Although the scores are very low, these fractions
537
have 100% amino acid sequence similarity with the respective similar protein. Moreover, these
538
sequences are considered new in this species and are reported for first time for G. grandidieri.
539
Fragments found in T. fuhrmanni corresponding to metalloproteinases has been never reported
540
before in this species. The enzymatic activity, together with the MS findings allows us to confirm
541
the presence of these proteins in the T. fuhrmanni venom. Although we did not find any
542
antimicrobial activity in this venom, we found a sequence similar to an antimicrobial peptide.
543
However, this peptide may not be present in sufficient concentration to elicit the antimicrobial
AC C
EP
TE D
529
30
ACCEPTED MANUSCRIPT
activity. Androctonus amoreuxi venom poses alpha and beta toxins commonly found in closely
545
related Buthidae species distributed in Africa, the Arabian Peninsula and India. Alpha toxins are
546
commonly found in A. amoreuxi venom. Chen et al previously reported 3 alpha toxins named
547
AamH1, AamH2 and AamH3, in the same scorpion (51). The A. amoreuxi sequence reported here,
548
although showed similarity with AamH1, AamH2 and AamH3, it is not 100% identical, indicating
549
that it may be a fragment of a new alpha toxin of A. amoreuxi. Beta toxins have been previously
550
reported in other Androctonus species like A. australis and A. mauritanicus. All sequences that we
551
reported matching beta toxins are identical with the respective similar toxin, indicating that these
552
toxins may be widely distributed among the species of the genus Androctonus. We found a
553
fragment of peptide corresponding to a sodium channel alpha-toxin eluting at 40% of ACN. Other
554
toxins affecting sodium channels isolated and identified in different Buthidae scorpions, commonly
555
elute between 30% and 50% of ACN (52-54). There have thus far not been any MS analyses
556
published for B. jacksoni. The preliminary MS/MS analysis of B. jacksoni indicates that this venom
557
has alpha toxins and other interesting peptides. In this venom, we also found a possible isomers of
558
the protein kinase reported in Mesobuthus gibbosus.
SC
M AN U
TE D
EP
559
RI PT
544
Cytotoxic activity found in the venom of T. fuhrmanni is related with the venom content reported
561
in the preliminary MS/MS analysis. In this venom, micrographs showed a loss of cohesion of MCF-7
562
cells when exposed to the venom fraction containing metalloproteinase-like fragments. This loss
563
of cohesion, together with the presence of the antimicrobial peptides, may cause direct damage to
564
the MCF-7 cells and loss of viability related with a membranolytic mechanism. These proteins play
565
an important role affecting internal cellular processes such as cell signaling, cell adhesion, invasion
566
and motility (43, 55). Although there is not enough evidence for scorpion metalloproteinases
567
enhancing any cytolytic activity in cancer cells, one snake Zn-metalloproteinase from Porthidium
AC C
560
31
ACCEPTED MANUSCRIPT
568
nasutum was reported to induce specific apoptosis activity in JurKat (T-cell acute lymphocytic
569
leukemia) and K562 (Chronic myeloid leukemia) cells (56).
570
metalloproteinases may be the main factor to propose these proteins in the venom of T.
571
fuhrmanni as promising anticancer proteins. Although the score of the fragment showing
572
sequence similarity with a DBP antimicrobial peptide from the scorpion Urodacus yaschenkoi,
573
found in the fraction with cytotoxic activity is very low, the presence of this kind of compounds in
574
T. fuhrmanni venom cannot be discarded, since we found a 100% similarity with the antimicrobial
575
peptide segment. Its presence could result in the synergistic activity proposed above. Further
576
analyses remain to be performed, such as the isolation, characterization and cytotoxic evaluation
577
of the fraction with metalloproteinase activity.
M AN U
SC
RI PT
The catalytic activity of
578
In the case of P. imperator venom, the presence of phospholipases and metalloproteinases may be
580
essentials for the anticancer activity explained as a synergistic activity and evidenced by the
581
complete loss of cohesion and cell viability. These PLA2 proteins may be the clue of the anticancer
582
activity. These esterases have been proposed as potential anticancer candidates mainly due to
583
their function in cell death (42). The anticancer activity of these proteins has been previously
584
reported in leukemia cells lines. The main mechanism by which these proteins mediate cell death
585
is the release of arachidonic acid (AA) (42, 57). AA can disrupt membranes by acting as a
586
detergent, or its metabolic products can stimulate caspase activation (42, 57). Although no PLA2
587
sequences were observed in the proteomic analysis of the fraction with cytotoxic activity, the
588
biochemical profile indicates the presence of these esterases in this venom. As exposed above,
589
metalloproteinases may be essential to induce a loss of cohesion of cells allowing the interaction
590
of phospholipases derivate with MCF-7 cells. The higher cytolytic activity of P. imperator venom,
591
compared with the isolated RP-HPLC fraction, explains the synergic mechanism proposed of the
AC C
EP
TE D
579
32
ACCEPTED MANUSCRIPT
phospholipases A2 and metalloproteinases. This synergic effect of the whole venom of P.
593
imperator showed a decrease in cell size suggesting an interaction of venom components with the
594
cell membrane surface. Chloride and potassium channels are overexpressed in some cancer cells,
595
like glioma cells, and become targets to anticancer peptides (58-61) and peptides affecting
596
potassium channels could play an important role in the cytotoxic activity as well. Some DBP,
597
isolated from the deathstalker scorpion Leiurus quinquestriatus (Buthidae), and is one the most
598
studied anticancer peptides affecting gliomas, among the deadliest forms of cancer (62-65).
SC
RI PT
592
M AN U
599 600 601
5. Conclusions
The biochemical profiles of all venoms indicate the presence of phospholipases A2,
603
metalloproteinases and serine-proteinases. All venoms showed a specific electrophoretic and
604
chromatographic profile. Venoms from P. imperator, G. grandidieri and T. fuhrmanni showed a
605
dose-response cytotoxic activity over MCF-7 mammary carcinogenic cells, proposing these venoms
606
as a potential source of anticancer molecules. No cytotoxic activity was seen with the venoms
607
from A. amoreuxi, B. jacksoni, and H. gentili. The activity may be mediated by a synergic
608
mechanism involving proteins and peptides like metalloproteinases, phospholipases antimicrobial
609
peptides and DBP peptides that targeting ionic channels. Metalloproteinases may be essential to
610
cause a loss of cohesion of cells allowing the interaction with the mentioned proteins and
611
peptides. In the case of T. fuhrmanni, the loss of cohesion and the presence of the antimicrobial
612
peptides, may cause direct damage to MCF-7 cells and a loss of viability related to a
613
membranolytic mechanism. We reported the first MS/MS and PTM of the venoms of B. jacksoni,
614
G. grandidieri and T. fuhrmanni. These venoms contain alpha toxins, neurotoxins, antimicrobial
AC C
EP
TE D
602
33
ACCEPTED MANUSCRIPT
615
peptides and proteins with enzymatic activity, in some cases never reported before in these
616
venoms.
RI PT
617 Acknowledgments
619
The authors are grateful with the Sostenibilidad program of the Universidad de Antioquia (UdeA),
620
and Comité para el Desarrollo de la Investigación CONADI, Universidad Cooperativa de Colombia.
621
This research was financed with the Project CIQF-211 through the Comité para el Desarrollo de la
622
Investigación (CODI-UdeA). AvdM is supported by a grant by Fundação para a Ciência e Tecnologia
623
(FCT, Portugal) under the Programa Operacional Potencial Humano – Quadro de Referência
624
Estratégico Nacional funds from the European Social Fund and Portuguese Ministério da Educação
625
e Ciência (SFRH/BPD/101057/2014). AvdM is also funded by FEDER funds through the Operational
626
Program for Competitiveness Factors - COMPETE and by National Funds through FCT - Foundation
627
for Science and Technology under the project FCT-PTDC/BIA-EVF/2687/2012 and FCOMP-01-0124-
628
FEDER-028340.
TE D
M AN U
SC
618
630
EP
629
Author Contributions
632
Sebastián Estrada-Gómez contributed with the conceptualization, writing – review & editing,
633
funding acquisition and methodology; Lyz Gomez-Rave contributed investigation and formal
634
analysis; Leidy Johana Vargas Muñoz contributed with funding acquisition, writing – review &
635
editing, investigation and formal analysis ; Arie van der Meijden contributed with scorpion
636
collection, venom extraction, funding acquisition, and writing – review & editing.
AC C
631
34
ACCEPTED MANUSCRIPT
637 References
639 640 641 642 643 644 645 646 647 648 649 650 651 652 653 654 655 656 657 658 659 660 661 662 663 664 665 666 667 668 669 670 671 672 673 674 675 676 677 678 679 680 681
1. Rodriguez AL. Comportamiento general de los accidentes provocados por animales venenosos en Colombia entre 2006 y 2010, atendidos en el Centro de Investigación, Gestión e Información Toxicológica de la Universidad Nacional de Colombia. Bogotá, Colombia.: Universidad Nacional de Colombia.; 2012. 2. Chippaux JP, Goyffon M. Epidemiology of scorpionism: A global appraisal. Acta tropica. 2008;107(2):71-9. 3. Ortiz E, Gurrola GB, Schwartz EF, Possani LD. Scorpion venom components as potential candidates for drug development. Toxicon. 2015;93:125-35. 4. Vargas Munoz LJ, Estrada-Gomez S. Purification and Characterization of Venom Components as Source for Antibiotics. Mini-Rev Org Chem. 2014;11(1):15-27. 5. Vargas Munoz LJ, Estrada-Gomez S, Escobar J. Snake and scorpion toxins venoms, a natural source of molecules with antimicrobial activity. CURARE. 2015;2(2):Article in press. 6. Estrada G, Villegas E, Corzo G. Spider venoms: a rich source of acylpolyamines and peptides as new leads for CNS drugs. Nat Prod Rep. 2007;24(1):145-61. 7. Rash LD, Hodgson WC. Pharmacology and biochemistry of spider venoms. Toxicon. 2002;40(3):225-54. 8. Cao LY, Dai C, Li ZJ, Fan Z, Song Y, Wu YL, et al. Antibacterial Activity and Mechanism of a Scorpion Venom Peptide Derivative In Vitro and In Vivo. Plos One. 2012;7(7). 9. Cao LY, Li ZJ, Zhang RH, Wu YL, Li WX, Cao ZJ. StCT2, a new antibacterial peptide characterized from the venom of the scorpion Scorpiops tibetanus. Peptides. 2012;36(2):213-20. 10. Corzo G, Escoubas P, Villegas E, Barnham KJ, He WL, Norton RS, et al. Characterization of unique amphipathic antimicrobial peptides from venom of the scorpion Pandinus imperator. Biochem J. 2001;359:35-45. 11. Corzo G, Villegas E, Gomez-Lagunas F, Possani LD, Belokoneva OS, Nakajima T. Oxyopinins, large amphipathic peptides isolated from the venom of the wolf spider Oxyopes kitabensis with cytolytic properties and positive insecticidal cooperativity with spider neurotoxins. J Biol Chem. 2002;277(26):23627-37. 12. Diaz P, D'Suze G, Salazar V, Sevcik C, Shannon JD, Sherman NE, et al. Antibacterial activity of six novel peptides from Tityus discrepans scorpion venom. A fluorescent probe study of microbial membrane Na+ permeability changes. Toxicon. 2009;54(6):802-17. 13. Miyashita M, Sakai A, Matsushita N, Hanai Y, Nakagawa Y, Miyagawa H. A Novel Amphipathic Linear Peptide with Both Insect Toxicity and Antimicrobial Activity from the Venom of the Scorpion Isometrus maculatus. Biosci Biotechnol Biochem. 2010;74(2):364-9. 14. Ramirez-Carreto S, Quintero-Hernandez V, Jimenez-Vargas JM, Corzo G, Possani LD, Becerril B, et al. Gene cloning and functional characterization of four novel antimicrobial-like peptides from scorpions of the family Vaejovidae. Peptides. 2012;34(2):290-5. 15. Cociancich S, Goyffon M, Bontems F, Bulet P, Bouet F, Menez A, et al. Purification and Characterization of a Scorpion Defensin, a 4kda Antibacterial Peptide Presenting Structural Similarities with Insect Defensins and Scorpion Toxins. Biochem Bioph Res Co. 1993;194(1):17-22. 16. Gaspar D, Veiga AS, Castanho MARB. From antimicrobial to anticancer peptides. A review. Frontiers in Microbiology. 2013;4. 17. Harris F, Dennison SR, Singh J, Phoenix DA. On the selectivity and efficacy of defense peptides with respect to cancer cells. Medicinal Research Reviews. 2013;33(1):190-234.
AC C
EP
TE D
M AN U
SC
RI PT
638
35
ACCEPTED MANUSCRIPT
EP
TE D
M AN U
SC
RI PT
18. Aroui S, Ram N, Appaix F, Ronjat M, Kenani A, Pirollet F, et al. Maurocalcine as a non toxic drug carrier overcomes doxorubicin resistance in the cancer cell line MDA-MB 231. Pharmaceutical Research. 2009;26(4):836-45. 19. Gao R, Zhang Y, Gopalakrishnakone P. Purification and N-terminal sequence of a serine proteinase-like protein (BMK-CBP) from the venom of the Chinese scorpion (Buthus martensii Karsch). Toxicon. 2008;52(2):348-53. 20. Guo X, Ma C, Du Q, Wei R, Wang L, Zhou M, et al. Two peptides, TsAP-1 and TsAP-2, from the venom of the Brazilian yellow scorpion, Tityus serrulatus: Evaluation of their antimicrobial and anticancer activities. Biochimie. 2013;95(9):1784-94. 21. WHO. Progress in the characterization of venoms and standardization of antivenoms. WHO offset publication. 1981(58):1-44. 22. Oukkache N, Chgoury F, Lalaoui M, Cano AA, Ghalim N. Comparison between two methods of scorpion venom milking in Morocco. The Journal of Venomous Animals and Toxins Including Tropical Diseases. 2013;19:5-. 23. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227(5259):680-5. 24. Fernandez J, Gutierrez JM, Angulo Y, Sanz L, Juarez P, Calvete JJ, et al. Isolation of an acidic phospholipase A2 from the venom of the snake Bothrops asper of Costa Rica: biochemical and toxicological characterization. Biochimie. 2010;92(3):273-83. 25. Cho W, Kezdy FJ. Chromogenic substrates and assay of phospholipases A2. Methods in enzymology. 1991;197:75-9. 26. Holzer M, Mackessy SP. An aqueous endpoint assay of snake venom phospholipase A2. Toxicon. 1996;34(10):1149-55. 27. Wang WJ, Shih CH, Huang TF. A novel P-I class metalloproteinase with broad substratecleaving activity, agkislysin, from Agkistrodon acutus venom. Biochemical and biophysical research communications. 2004;324(1):224-30. 28. Patiño AC, Pereañez JA, Gutiérrez JM, Rucavado A. Biochemical and biological characterization of two serine proteinases from Colombian Crotalus durissus cumanensis snake venom. Toxicon. 2013;63(0):32-43. 29. Kishimoto M, Takahashi T. A spectrophotometric microplate assay for L-amino acid oxidase. Analytical biochemistry. 2001;298(1):136-9. 30. Bauer AW, Kirby WM, Sherris JC, Turck M. Antibiotic susceptibility testing by a standardized single disk method. American journal of clinical pathology. 1966;45(4):493-6. 31. Barona J, Batista CV, Zamudio FZ, Gomez-Lagunas F, Wanke E, Otero R, et al. Proteomic analysis of the venom and characterization of toxins specific for Na+ - and K+ -channels from the Colombian scorpion Tityus pachyurus. Biochimica et biophysica acta. 2006;1764(1):76-84. 32. Rodriguez de la Vega RC, Possani LD. Overview of scorpion toxins specific for Na+ channels and related peptides: biodiversity, structure-function relationships and evolution. Toxicon. 2005;46(8):831-44. 33. Cintra ACO, De Toni LGB, Sartim MA, Franco JJ, Caetano RC, Murakami MT, et al. Batroxase, a new metalloproteinase from B. atrox snake venom with strong fibrinolytic activity. Toxicon. 2012;60(1):70-82. 34. Seyedian R, Pipelzadeh MH, Jalali A, Kim E, Lee H, Kang C, et al. Enzymatic analysis of Hemiscorpius lepturus scorpion venom using zymography and venom-specific antivenin. Toxicon. 2010;56(4):521-5. 35. Xia X, Ma Y, Xue S, Wang A, Tao J, Zhao Y, et al. Cloning and molecular characterization of BumaMPs1, a novel metalloproteinases from the venom of scorpion Buthus martensi Karsch. Toxicon. 2013;76:234-8.
AC C
682 683 684 685 686 687 688 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729
36
ACCEPTED MANUSCRIPT
EP
TE D
M AN U
SC
RI PT
36. Estrada-Gomez S, Munoz LJ, Lanchero P, Latorre CS. Partial Characterization of Venom from the Colombian Spider Phoneutria Boliviensis (Aranae:Ctenidae). Toxins (Basel). 2015;7(8):2872-87. 37. Fletcher Jr PL, Fletcher MD, Weninger K, Anderson TE, Martin BM. Vesicle-associated membrane protein (VAMP) cleavage by a new metalloprotease from the Brazilian scorpion Tityus serrulatus. J Biol Chem. 2010;285(10):7405-16. 38. Ortiz E, Rendón-Anaya M, Rego SC, Schwartz EF, Possani LD. Antarease-like Znmetalloproteases are ubiquitous in the venom of different scorpion genera. Biochimica et Biophysica Acta (BBA) - General Subjects. 2014;1840(6):1738-46. 39. Almeida FM, Pimenta AMC, De Figueiredo SG, Santoro MM, Martin-Eauclaire MF, Diniz CR, et al. Enzymes with gelatinolytic activity can be found in Tityus bahiensis and Tityus serrulatus venoms. Toxicon. 2002;40(7):1041-5. 40. de Oliveira F, de Sousa BB, Mamede CCN, de Morais NCG, de Queiroz MR, da Cunha Pereira DF, et al. Biochemical and functional characterization of BmooSP, a new serine protease from Bothrops moojeni snake venom. Toxicon. 2016;111:130-8. 41. Estrada-Gómez S, Vargas Muñoz LJ, Saldarriaga-Córdoba M, Quintana Castillo JC. Venom from Opisthacanthus elatus scorpion of Colombia, could be more hemolytic and less neurotoxic than thought. Acta tropica. 2016;153:70-8. 42. Cummings BS, McHowat J, Schnellmann RG. Phospholipase A(2)s in cell injury and death. The Journal of pharmacology and experimental therapeutics. 2000;294(3):793-9. 43. Morgenstern D, Rohde BH, King GF, Tal T, Sher D, Zlotkin E. The tale of a resting gland: transcriptome of a replete venom gland from the scorpion Hottentotta judaicus. Toxicon. 2011;57(5):695-703. 44. Suranse V, Sawant NS, Paripatyadar SV, Krutha K, Paingankar MS, Padhye AD, et al. First molecular phylogeny of scorpions of the family Buthidae from India. Mitochondrial DNA Part A DNA mapping, sequencing, and analysis. 2016:1-6. 45. Sharma PP, Fernández R, Esposito LA, González-Santillán E, Monod L. Phylogenomic resolution of scorpions reveals multilevel discordance with morphological phylogenetic signal. Proceedings of the Royal Society of London B: Biological Sciences. 2015;282(1804). 46. Delepierre M, Prochnicka-Chalufour A, Possani LD. A novel potassium channel blocking toxin from the scorpion Pandinus imperator: A 1H NMR analysis using a nano-NMR probe. Biochemistry-Us. 1997;36(9):2649-58. 47. Guijarro JI, M'Barek S, Gomez-Lagunas F, Garnier D, Rochat H, Sabatier JM, et al. Solution structure of Pi4, a short four-disulfide-bridged scorpion toxin specific of potassium channels. Protein science : a publication of the Protein Society. 2003;12(9):1844-54. 48. Marshall DL, Harvey AL. Block of potassium channels and facilitation of acetylcholine release at the neuromuscular junction by the venom of the scorpion, Pandinus imperator. Toxicon. 1989;27(4):493-8. 49. Pappone PA, Lucero MT. Pandinus imperator scorpion venom blocks voltage-gated potassium channels in GH3 cells. The Journal of general physiology. 1988;91(6):817-33. 50. Tenenholz TC, Rogowski RS, Collins JH, Blaustein MP, Weber DJ. Solution structure for Pandinus toxin K-alpha (PiTX-K alpha), a selective blocker of A-type potassium channels. Biochemistry-Us. 1997;36(10):2763-71. 51. Chen T, Walker B, Zhou M, Shaw C. Molecular cloning of a novel putative potassium channel-blocking neurotoxin from the venom of the North African scorpion, Androctonus amoreuxi. Peptides. 2005;26(5):731-6.
AC C
730 731 732 733 734 735 736 737 738 739 740 741 742 743 744 745 746 747 748 749 750 751 752 753 754 755 756 757 758 759 760 761 762 763 764 765 766 767 768 769 770 771 772 773 774 775
37
ACCEPTED MANUSCRIPT
EP
TE D
M AN U
SC
RI PT
52. Espino-Solis GP, Estrada G, Olamendi-Portugal T, Villegas E, Zamudio F, Cestele S, et al. Isolation and molecular cloning of beta-neurotoxins from the venom of the scorpion Centruroides suffusus suffusus. Toxicon. 2011;57(5):739-46. 53. Saucedo AL, del Rio-Portilla F, Picco C, Estrada G, Prestipino G, Possani LD, et al. Solution structure of native and recombinant expressed toxin CssII from the venom of the scorpion Centruroides suffusus suffusus, and their effects on Nav1.5 sodium channels. Biochimica et biophysica acta. 2012;1824(3):478-87. 54. Valdez-Cruz NA, Davila S, Licea A, Corona M, Zamudio FZ, Garcia-Valdes J, et al. Biochemical, genetic and physiological characterization of venom components from two species of scorpions: Centruroides exilicauda Wood and Centruroides sculpturatus Ewing. Biochimie. 2004;86(6):387-96. 55. Jones GC, Riley GP. ADAMTS proteinases: A multi-domain, multi-functional family with roles in extracellular matrix turnover and arthritis. Arthritis Research and Therapy. 2005;7(4):1609. 56. Bonilla-Porras AR, Vargas LJ, Jimenez-Del-Rio M, Nuñez V, Velez-Pardo C. Purification of nasulysin-1: A new toxin from Porthidium nasutum snake venom that specifically induces apoptosis in leukemia cell model through caspase-3 and apoptosis-inducing factor activation. Toxicon. 2016;120:166-74. 57. Atsumi G, Tajima M, Hadano A, Nakatani Y, Murakami M, Kudo I. Fas-induced arachidonic acid release is mediated by Ca2+-independent phospholipase A2 but not cytosolic phospholipase A2, which undergoes proteolytic inactivation. The Journal of biological chemistry. 1998;273(22):13870-7. 58. Basrai D, Kraft R, Bollensdorff C, Liebmann L, Benndorf K, Patt S. BK channel blockers inhibit potassium-induced proliferation of human astrocytoma cells. NeuroReport. 2002;13(4):4037. 59. Brismar T, Collins VP. Potassium and sodium channels in human malignant glioma cells. Brain Res. 1989;480(1-2):259-67. 60. Brismar T, Collins VP. Potassium channels in human glioma cells. Pflügers Archiv European Journal of Physiology. 1989;414(1 Supplement):S137-S8. 61. Ransom CB, Sontheimer H. BK channels in human glioma cells. Journal of neurophysiology. 2001;85(2):790-803. 62. DeBin JA, Maggio JE, Strichartz GR. Purification and characterization of chlorotoxin, a chloride channel ligand from the venom of the scorpion. American Journal of Physiology - Cell Physiology. 1993;264(2 33-2):C361-C9. 63. Deshane J, Garner CC, Sontheimer H. Chlorotoxin inhibits glioma cell invasion via matrix metalloproteinase-2. J Biol Chem. 2003;278(6):4135-44. 64. Mamelak AN. Targeted antitumor therapy with the scorpion venom chlorotoxin. Drugs of the Future. 2011;36(8):615-25. 65. YANG Rui PF, LIU Hui, CAO Zhi Jian, LI Wen Xin *, MAO Xin, JIANG Da He. Functional Analysis of a Gene Encoding a Chlorotoxin-like Peptide Derived from Scorpion Toxin. Chinese Journal of Biochemistry and Molecular Biol. 2005;21(01):19-23.
AC C
776 777 778 779 780 781 782 783 784 785 786 787 788 789 790 791 792 793 794 795 796 797 798 799 800 801 802 803 804 805 806 807 808 809 810 811 812 813 814 815 816 817
38
ACCEPTED MANUSCRIPT
Characterizing the biological and biochemical profile of six different scorpion venoms from the Buthidae and Scorpionidae family.
Highlights.
•
AC C
EP
TE D
M AN U
SC
•
Venoms showed the presence of proteolytic and phospholipase activity. All venoms analyzed contained defensin-like proteins, alpha toxins, metalloproteinases, neuropeptides, DBP affecting ion channels, DBP with antimicrobial activity, among others. Venoms from P. imperator, G. grandidieri and T. fuhrmani showed a dose-dependent cytotoxic activity over MCF-7 cells. Two isolated RP-HPLC fractions from P. imperator and T. fuhrmanni showed cytotoxic activity over MCF-7.
RI PT
• •